🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Australia / NCT05645861
Active, not recruiting Not applicable

MAnagement of Systolic Blood Pressure During Thrombectomy by Endovascular Route for Acute Ischaemic STROKE

NCT05645861 · tracked via the Priya Life Science Australia tracker
Sponsor
Auckland City Hospital
Phase
Not applicable
Started
2019-11-28
Last updated
2026-01-05

Condition(s) studied

StrokeEmbolus CerebralBlood Pressure

Investigational drug(s) / intervention(s)

Blood pressure management of Systolic Blood Pressure to maintain target range +/- 10 mmHg

Blood pressure management of Systolic Blood Pressure to maintain target range +/- 10 mmHg: Techniques used to target SBP will not be controlled for and will be at the discretion of the procedural anaesthetist to manage blood pressure, this can include vasopressors, intravenous fluids, titration of anaesthetic maintenance drugs and use of other vasoactive drugs.

Study summary

Stroke is the third most common cause of death in New Zealand and is one of the leading causes of long-term disability at all ages. A life-saving clot retrieval procedure can save lives and prevent disability of patients with ischaemic stroke who get to hospital in time. In New Zealand, 90% of clot retrieval procedures are performed under general anaesthesia. Many anaesthetic drugs can affect blood pressure (BP) and blood flow within the brain. Increasing BP during the procedure could provide additional benefits in this devastating disease. A large trial is needed to investigate BP management during clot retrieval.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients diagnosed with anterior circulation stroke (ICA or proximal M1 or M2 segment of MCA) treated with ECR within 6 hrs of stroke onset and ECR patients presenting within 6-24 hours and favourable penumbra on perfusion scanning (see criteria 1-3). Additional criteria in the 6 to 24-hour window. 1. 'wake up' stroke; CT with no (or at most minimal) acute infarction or 2. patient 80 years or older (NIHSS of 10 and infarct volume less than 21 ml on DWI or CT perfusion-CBF) 3. patient less than 80 years (NIHSS of 10 and infarct volume less than 31 ml on DWI or CT perfusion-CBF NIHSS of 20 and infarct volume less than 51 ml on DWI or CT perfusion-CBF). Exclusion Criteria: * Rescue"' procedures eg acute ischaemic stroke associated with major medical procedures such as coronary artery stenting and coronary artery bypass * pre-stroke mRS\>=3 * not having GA * terminal illness with expected survival \<1 year * pregnancy * cardiovascular conditions where BP targeting will be contra-indicated * unable to participate in 3-month follow up

Primary outcome measure(s)

Trial sites (6)

FacilityCityRegionStatus
Royal North Shore Hospital Sydney New South Wales
Gold Coast University Hospital Southport Queensland
Metro South Hospital and Health Service via the Princess Alexandra Hospital Woolloongabba Queensland
Auckland City Hopsital Auckland Auckland
Christchurch Hospital Christchurch Canterbury
Wellington Regional Hospital Newton Wellington Region

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05645861 on ClinicalTrials.gov ↗ ← All trials in Australia